Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo.
Dong
Yunzhou
Y
ection of Endocrinology and Diabetes, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Zhang
Miao
M
Wang
Shuangxi
S
Liang
Bin
B
Zhao
Zhengxing
Z
Liu
Chao
C
Wu
Mingyuan
M
Choi
Hyoung Chul
HC
Lyons
Timothy J
TJ
Zou
Ming-Hui
MH
D055372:AMP-Activated Protein Kinases / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D001011:Aorta; D001057:Apolipoproteins E / Q000172:deficiency; D002417:Cattle; D003433:Crosses, Genetic; D004721:Endoplasmic Reticulum / Q000502:physiology*; D004730:Endothelium, Vascular / Q000166:cytology; D004789:Enzyme Activation; D005786:Gene Expression Regulation; D017127:Glycation End Products, Advanced; D006801:Humans; D008077:Lipoproteins, LDL / Q000037:antagonists & inhibitors / Q000502:physiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D034741:RNA, Small Interfering / Q000235:genetics; D014471:Umbilical Veins / Q000502:physiology; D000093844:Glycated Proteins
D055372:AMP-Activated Protein Kinases; D001057:Apolipoproteins E; D017127:Glycation End Products, Advanced; D008077:Lipoproteins, LDL; D034741:RNA, Small Interfering; C031797:glycated lipoproteins, LDL; D000093844:Glycated Proteins; C099252:oxidized low density lipoprotein; C534978:Prkaa2 protein, mouse